Back to COGT
TCG Crossover Management, LLC → COGT
TCG Crossover Management, LLC COGT Position History
Cogent Biosciences, Inc. • Healthcare
Quarters held
4
Latest value
$80.1M
Q3 2026
Peak value
$208.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $208.4M |
| Q1 2026 | $190.4M |
| Q2 2026 | $187.9M |
| Q3 2026 | $80.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $80.1M | 2.50M | — | — |
| Q2 2026 | $187.9M | 4.85M | — | — |
| Q1 2026 | $190.4M | 4.95M | — | — |
| Q4 2025 | $208.4M | 5.87M | — | — |
Other funds holding COGT
$868.7M
$808M
$756M
$706.8M
Other TCG Crossover Management, LLC positions
AAVXF
$959MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$800.6MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$721.7MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$362.7MABIVAX SA AMERICAN DEPOSITARY SHARES
TNGX
$283.9MTANGO THERAPEUTICS INC
CGON
$260.8MCG ONCOLOGY INC
CGON
$260.2MCG ONCOLOGY INC
CGON
$248.4MCG ONCOLOGY INC